Osteologický bulletin, 2011 (vol. 16), issue 3

EditorialEditorial

V. Palička

Clin Osteol 2011; 16(3): 63

Diabetic osteopathy in type 1 diabetics using insulin pump therapyReview articles

I. Kučerová, L. Dohnalová

Clin Osteol 2011; 16(3): 64-68

Diabetic osteopathy is diffuse bone involvement in diabetics. In clinical practice, it is confirmed by decreased bone mineral density (BMD). It was first described more than 80 years ago as radiological signs of bone growth retardation in diabetic children [1]. As a re­ sult of an increasing knowledge of the pathophysiology of bone metabolism, the past 20 years have witnessed better understanding of the mechanisms of bone involvement, especially in type 1 diabetics. However, their impact on the manifestation of diabetic osteopathy remains unclear. The association between diabetes and bone disease is complex, depending on the course and type of diabetes,...

Estimation of bone microarchitecture pattern from AP spine DXA scans using the trabecular bone score (TBS): an added value in clinical routine for the patient: a short reviewReview articles

D. Hans, R. Winzenrieth

Clin Osteol 2011; 16(3): 69-77

Intrinsically it is accepted that defining osteoporosis on the sole basis of bone mineral density (BMD) reached its limit. Indeed, the multifactorial aspect of this disease encourages the current definition of osteoporosis to evolve towards a complex risk model based on Clinical Risk Factor (CRF) and BMD. Considering these CRFs along with BMD in the assessment of fracture risk, increases the sen­ sitivity of screening without sacrificing specificity. Whereas part of the limit of the current use of DXA is currently being addressed by the concomitant use of CRFs it only partially takes into account the information of bone micro-architecture. Therefore,...

New possibilities of DXA scans and their limitationsReview articles

V. Vyskočil, T. Pavelka

Clin Osteol 2011; 16(3): 78-86

Currently, there are several innovations that extend the standard user software for bone densitometers, which allow you to get more information on the measured areas of the skeleton. Creating a functional evaluation which would correspond to the risk of clinical frac­ tures was the reason for the development of the Fracture Risk Assessment Tool (FRAX) and search for other imaging methods such as quantitative and high-resolution MRI to create 3D trabecular microarchitecture images. For the evaluation of trabecular bone mic­ roarchitecture, it is also possible to use 2D projection, which can be obtained using standard radiographs or DXA scans. Another...

Vitamin D - state-of-the-art knowledge, effect and role in human medicineNews

P. Novosad, P. Hrdý, P. Fojtík

Clin Osteol 2011; 16(3): 87-95

Vitamin D is one of the oldest hormones, having been produced by life forms for over 750 million years. Phytoplankton, zooplankton and most animals that are exposed to sunlight have the capacity to produce vitamin D. In humans, vitamin D is critically important for the development, growth and maintenance of a healthy body, from birth until death. Intensive research is underway in many me­ dicinal disciplines or clinical diagnoses. Current medical research of vitamin D is considered very important.

Certification of clinical osteologyInformations

V. Palička, V. Vysočil

Clin Osteol 2011; 16(3): 96

Programme of the 14th International Congress Czech and Slovak OsteologistsInformations

Clin Osteol 2011; 16(3): 98-104

Abstracts - 14th International Congress on OsteoporosisAbstracts

Clin Osteol 2011; 16(3): 105-128


Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.